CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announced that an ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Nck modulator is being studied in 30 patients with ...
Former Genzyme CEO Henri Termeer led a new investment round for Artax Biopharma, a Cambridge startup developing small molecule immunomodulator drugs that treat autoimmune disease. The drugs work as a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Artax Biopharma, a clinical stage biotechnology company developing first-in-class highly selective oral therapies for the treatment of autoimmune diseases, has ...
CAMBRIDGE, Mass., Sept. 17, 2020 /PRNewswire/ -- Artax Biopharma, Inc., a biotechnology company focused on transforming autoimmune disease treatment, announces today that the United States Patent and ...
Artax , a champion sprinter who was attacked by a drunken racegoer in a stakes on the 1999 Preakness Stakes (gr. I) undercard, died Jan. 8 in an equine hospital in Rio Grande do Sul, Brazil, because ...
CAMBRIDGE, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announced the ...
Retired trainer Louis Albertrani, who conditioned 1999 champion sprinter Artax, died July 13 at his home in New Castle, Del., at the age of 67. Albertrani's brother, Tom, also a retired trainer, said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results